Financhill
Sell
34

CCCC Quote, Financials, Valuation and Earnings

Last price:
$2.68
Seasonality move :
-24.32%
Day range:
$2.57 - $2.76
52-week range:
$1.09 - $5.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.32x
P/B ratio:
1.68x
Volume:
2M
Avg. volume:
1.6M
1-year change:
-31.54%
Market cap:
$258.8M
Revenue:
$35.6M
EPS (TTM):
-$1.67

Earnings Data

Next earnings date for CCCC
Feb 26
2026
Most recent earnings per share
-$0.44
Missed by $0.05
(Nov 6/2025)
Consensus Estimate
-$0.39
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CCCC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $4.5M -- -- -$0.39 --
11/06/2025 Q3 $6.3M $11.2M -$0.44 -$0.39 -$0.05
08/07/2025 Q2 $6.6M $6.5M -$0.37 -$0.38 $0.02
05/07/2025 Q1 $3.5M $7.2M -$0.37 -$0.43 $0.06
02/27/2025 Q4 $4.4M $5.2M -$0.49 -$0.45 -$0.04
11/01/2024 Q3 $4.6M $15.4M -$0.35 -$0.33 -$0.02
08/01/2024 Q2 $4.8M $12M -$0.26 -$0.18 -$0.08
05/08/2024 Q1 $9.3M $3M -$0.41 -$0.26 -$0.15
02/22/2024 Q4 $3.2M $3.3M -$0.68 -$0.69 $0.01
11/01/2023 Q3 -- -- -$0.55 -$0.65 $0.10
08/08/2023 Q2 -- -- -$0.73 -$0.69 -$0.04
05/04/2023 Q1 -- -- -$0.71 -$0.75 $0.04
02/23/2023 Q4 -- -- -$0.76 -$0.59 -$0.17
11/03/2022 Q3 -- -- -$0.65 -$0.61 -$0.04
08/04/2022 Q2 -- -- -$0.56 -$0.63 $0.07
05/05/2022 Q1 -- -- -$0.65 -- --
02/24/2022 Q4 -- -- -$0.31 -- --
11/10/2021 Q3 -- -- -$0.51 -- --
08/11/2021 Q2 -- -- -$0.51 -- --
05/13/2021 Q1 -- -- -$0.49 -- --
03/11/2021 Q4 -- -- -$0.27 -- --
11/12/2020 Q3 -- -- -$0.66 -- --
06/30/2020 Q2 -- -- -$0.34 -- --
03/31/2020 Q1 -- -- -$0.81 -- --
12/31/2019 Q4 -- -- -$0.69 -- --
09/30/2019 Q3 -- -- -$0.71 -- --

C4 Therapeutics, Inc. Earnings Questions

  • How Much did C4 Therapeutics, Inc. Generate in Revenue Last Quarter?

    C4 Therapeutics, Inc. reported $11.2M worth of top line sales in its most recent quarter.

  • Did C4 Therapeutics, Inc. Beat Earnings Last Quarter?

    C4 Therapeutics, Inc. announced earnings per share of -$0.44 which represents a miss of analyst forecast a -$0.39 per share.

  • Is C4 Therapeutics, Inc. Profitable?

    C4 Therapeutics, Inc. reported $9.2M that represents $0.13 per share over the last quarter.

  • What is the Analyst Consensus for C4 Therapeutics, Inc. EPS Next Year?

    C4 Therapeutics, Inc.'s earnings are forecast to decrease from -$1.52 per share to -$1.31 per share next year representing a decrease of -0.13%.

  • When is C4 Therapeutics, Inc.'s Earnings Date?

    C4 Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock